SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia
Authors
Keywords
Hypersensitivity, Hepatotoxicity, Hyperlipidemia, Thromboembolism, Pancreatitis
Journal
Clinical Lymphoma Myeloma & Leukemia
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-07-16
DOI
10.1016/j.clml.2021.07.009
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients
- (2021) Sie Chong Doris Lau et al. Frontiers in Pediatrics
- How I Treat: Selecting CD19 Targeted Immunotherapies in Adult Patients with Advanced Acute Lymphoblastic Leukemia
- (2020) Ibrahim Aldoss et al. BLOOD
- Prospective, real‐time monitoring of pegylated Escherichia coli and Erwinia asparaginase therapy in childhood acute lymphoblastic leukaemia and non‐Hodgkin lymphoma in Belgium
- (2020) Veerle Mondelaers et al. BRITISH JOURNAL OF HAEMATOLOGY
- Individualized Asparaginase Dosing in Childhood Acute Lymphoblastic Leukemia
- (2020) Robin Q.H. Kloos et al. JOURNAL OF CLINICAL ONCOLOGY
- Successful Management of l-Asparaginase–Associated Pancreatitis With Octreotide and Pegylated Asparaginase in 2 Patients With Acute Lymphoblastic Leukemia: Is There a Different Rare Warning Sign of Hypoglycemia for l-Asparaginase–Associated Pancreatitis?
- (2020) Sultan Aydin Köker et al. CLINICAL THERAPEUTICS
- Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group
- (2020) Sumit Gupta et al. JOURNAL OF CLINICAL ONCOLOGY
- Dyslipidemia at diagnosis of childhood acute lymphoblastic leukemia
- (2020) Pernille Rudebeck Mogensen et al. PLoS One
- Butter in blood: hypertriglyceridemia secondary to pegylated
- (2020) C Singh et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Fenofibrate reduces osteonecrosis without affecting antileukemic efficacy in dexamethasone treated mice
- (2020) Emily R. Finch et al. HAEMATOLOGICA
- Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia
- (2020) Mark B. Geyer et al. HAEMATOLOGICA
- Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion
- (2020) Patrick W Burke et al. ESMO Open
- Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia
- (2020) Alaeddin Khalil et al. HAEMATOLOGICA
- Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia
- (2020) Sofie Gottschalk Højfeldt et al. BLOOD
- Genetics of osteonecrosis in pediatric acute lymphoblastic leukemia and general populations
- (2020) Wenjian Yang et al. BLOOD
- A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403
- (2019) Wendy Stock et al. BLOOD
- Pegaspargase-induced hypertriglyceridemia in a patient with acute lymphoblastic leukemia
- (2019) Kimberly M Lau et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)—Rationale and Design
- (2019) Danshi Li et al. THROMBOSIS AND HAEMOSTASIS
- L-carnitine does not ameliorate asparaginase-associated hepatotoxicity in a C57BL6 mouse model
- (2019) Yiwei Liu et al. LEUKEMIA & LYMPHOMA
- Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study
- (2019) Birgitte Klug Albertsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Universal premedication and therapeutic drug monitoring for asparaginase‐based therapy prevents infusion‐associated acute adverse events and drug substitutions
- (2019) Stacy L. Cooper et al. PEDIATRIC BLOOD & CANCER
- Antibodies Predict Pegaspargase Allergic Reactions and Failure of Rechallenge
- (2019) Yiwei Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis
- (2019) Natasha Kamal et al. Hepatology International
- Levocarnitine does not impair chemotherapy cytotoxicity against acute lymphoblastic leukemia
- (2019) Jessica L. Sea et al. LEUKEMIA & LYMPHOMA
- Asparaginase activities during intensified treatment with pegylated E. coli asparaginase in adults with newly-diagnosed acute lymphoblastic leukemia
- (2019) Claudia Lanvers-Kaminsky et al. LEUKEMIA & LYMPHOMA
- Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age
- (2019) Cecilie U. Rank et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia
- (2019) Benjamin A. Derman et al. LEUKEMIA & LYMPHOMA
- Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker
- (2019) Robin Kloos et al. BRITISH JOURNAL OF HAEMATOLOGY
- Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia – A NOPHO ALL2008 study
- (2019) Kirsten Brunsvig Jarvis et al. THROMBOSIS RESEARCH
- Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years
- (2018) Cecilie Utke Rank et al. BLOOD
- Ca 2+ signalling underlying pancreatitis
- (2018) J.V. Gerasimenko et al. CELL CALCIUM
- Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature
- (2018) Rachael R. Schulte et al. LEUKEMIA & LYMPHOMA
- Pegaspargase-related high-grade hepatotoxicity in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not predict recurrent hepatotoxicity with subsequent doses
- (2018) Patrick W. Burke et al. LEUKEMIA RESEARCH
- Association between body mass index and pancreatitis in children with acute lymphoblastic leukemia
- (2018) Pernille R. Mogensen et al. PEDIATRIC BLOOD & CANCER
- Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia
- (2018) Signe Sloth Mogensen et al. PEDIATRIC BLOOD & CANCER
- THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during inudction therapy of acute lymphoblastic leukemia in children and adolescents
- (2018) Jeanette Greiner et al. HAEMATOLOGICA
- Insulin-dependent diabetes: A chronic complication to acute pancreatitis in childhood acute lymphoblastic leukemia
- (2018) Benjamin Ole Wolthers et al. PEDIATRIC BLOOD & CANCER
- A cost-effectiveness analysis of Erwinia asparaginase therapy in children with acute lymphoblastic leukemia
- (2018) Robin Q. H. Kloos et al. PEDIATRIC BLOOD & CANCER
- Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008
- (2018) Sofie G. Højfeldt et al. BRITISH JOURNAL OF HAEMATOLOGY
- Trypsin encoding PRSS1-PRSS2 variation influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group report
- (2018) Benjamin O. Wolthers et al. HAEMATOLOGICA
- Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia
- (2017) Signe Sloth Mogensen et al. HAEMATOLOGICA
- Prophylactic use of octreotide for asparaginase-induced acute pancreatitis
- (2017) Sachi Sakaguchi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Risk Factors for Asparaginase-associated Pancreatitis
- (2017) Judy-April Oparaji et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study
- (2017) Benjamin O Wolthers et al. LANCET ONCOLOGY
- Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia
- (2017) N Toft et al. LEUKEMIA
- PEGging down risk factors for peg-asparaginase hepatotoxicity in patients with acute lymphoblastic leukemia
- (2017) Caitlin R. Rausch et al. LEUKEMIA & LYMPHOMA
- Predictors of hepatotoxicity and pancreatitis in children and adolescents with acute lymphoblastic leukemia treated according to contemporary regimens
- (2017) Christopher C. Denton et al. PEDIATRIC BLOOD & CANCER
- Hypertriglyceridemia during asparaginase treatment in children with acute lymphoblastic leukemia correlates with antithrombin activity in adolescents
- (2017) Lisa Persson et al. PEDIATRIC BLOOD & CANCER
- Hyperlipidemia is a risk factor for osteonecrosis in children and young adults with acute lymphoblastic leukemia
- (2017) Signe Sloth Mogensen et al. HAEMATOLOGICA
- A minor role of asparaginase in predisposing to cerebral venous thromboses in adult acute lymphoblastic leukemia patients
- (2017) Saara Roininen et al. Cancer Medicine
- Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen
- (2017) Trevor N Christ et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Levocarnitine and vitamin B complex for the treatment of pegaspargase-induced hepatotoxicity: A case report and review of the literature
- (2017) Alison Blackman et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Venous thromboembolism prevention during asparaginase-based therapy for acute lymphoblastic leukemia
- (2016) H. Sibai et al. Current Oncology
- Osteonecrosis in children with acute lymphoblastic leukemia
- (2016) Marina Kunstreich et al. HAEMATOLOGICA
- Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation
- (2016) I. M. van der Sluis et al. HAEMATOLOGICA
- Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia
- (2016) Chengcheng Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus
- (2016) Kjeld Schmiegelow et al. LANCET ONCOLOGY
- Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial
- (2016) B Patel et al. LEUKEMIA
- Pegaspargase hypersensitivity reactions: intravenous infusion versus intramuscular injection – a review
- (2016) Lynda Kwon Beaupin et al. LEUKEMIA & LYMPHOMA
- The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance
- (2016) Troy Z. Horvat et al. LEUKEMIA RESEARCH
- Asparaginase-associated pancreatitis is not predicted by hypertriglyceridemia or pancreatic enzyme levels in children with acute lymphoblastic leukemia
- (2016) Raheel Altaf Raja et al. PEDIATRIC BLOOD & CANCER
- Allergic-like reactions to asparaginase: Atypical allergies without asparaginase inactivation
- (2016) Robin Q. H. Kloos et al. PEDIATRIC BLOOD & CANCER
- Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia
- (2016) H Alachkar et al. PHARMACOGENOMICS JOURNAL
- Osteonecrosis in children with acute lymphoblastic leukemia
- (2016) Marina Kunstreich et al. HAEMATOLOGICA
- Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation
- (2016) I. M. van der Sluis et al. HAEMATOLOGICA
- The post-thrombotic syndrome
- (2016) S. R. Kahn Hematology-American Society of Hematology Education Program
- PEG-asparaginase induced severe hypertriglyceridemia
- (2016) Rodolfo J. Galindo et al. Archives of Endocrinology Metabolism
- High triglyceride is a risk factor for silent osteonecrosis of the femoral head in systemic lupus erythematosus
- (2015) Takeshi Kuroda et al. CLINICAL RHEUMATOLOGY
- Toxicity profile of repeated doses of PEG-asparaginase incorporated into a pediatric-type regimen for adult acute lymphoblastic leukemia
- (2015) Ibrahim Aldoss et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia
- (2015) Nina Toft et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Acute pancreatitis
- (2015) Paul Georg Lankisch et al. LANCET
- Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial
- (2015) Andrew E Place et al. LANCET ONCOLOGY
- Ammonia Levels Should Not Be Used as a Surrogate Marker of Levels of Asparaginase Activity in Acute Lymphoblastic Leukemia Patients
- (2015) Wing H. Tong et al. PEDIATRIC BLOOD & CANCER
- A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia
- (2014) Wing H. Tong et al. BLOOD
- HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies
- (2014) C. A. Fernandez et al. BLOOD
- Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL)
- (2014) Michael E. Rytting et al. CANCER
- Severe hypertriglyceridaemia during therapy for childhood acute lymphoblastic leukaemia
- (2014) Deepa Bhojwani et al. EUROPEAN JOURNAL OF CANCER
- Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPARγ expression and activating Wnt signaling pathway
- (2014) Yini Jiang et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- The toxicity of very prolonged courses of PEGasparaginase or Erwinia asparaginase in relation to asparaginase activity, with a special focus on dyslipidemia
- (2014) W. H. Tong et al. HAEMATOLOGICA
- Pharmacokinetic and Pharmacodynamic Properties of Calaspargase PegolEscherichia coliL-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Study AALL07P4
- (2014) Anne L. Angiolillo et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacokinetics-Based Integration of Multiple Doses of Intravenous Pegaspargase in a Pediatric Regimen for Adults With Newly Diagnosed Acute Lymphoblastic Leukemia
- (2014) Dan Douer et al. JOURNAL OF CLINICAL ONCOLOGY
- PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol
- (2014) Louise Tram Henriksen et al. PEDIATRIC BLOOD & CANCER
- Safety profile of asparaginaseErwinia chrysanthemiin a large compassionate-use trial
- (2014) Paul V. Plourde et al. PEDIATRIC BLOOD & CANCER
- Successful Use of Octreotide as a Chemoprotectant for Prevention of PEG-Asparaginase-Induced Pancreatitis
- (2014) Larry W. Buie et al. PHARMACOTHERAPY
- Long-term psychological consequences of symptomatic pulmonary embolism: a qualitative study
- (2014) Simon Noble et al. BMJ Open
- L-Carnitine Ameliorates L-Asparaginase-Induced Acute Liver Toxicity in Steatotic Rat Livers
- (2013) Anne Roesmann et al. CHEMOTHERAPY
- Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol
- (2013) Nina Toft et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Successful treatment ofl-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors
- (2013) Chadi Al-Nawakil et al. LEUKEMIA & LYMPHOMA
- Racial differences in nonalcoholic fatty liver disease in the U.S. population
- (2013) Andrea L. C. Schneider et al. Obesity
- The coagulopathy and thrombotic risk associated with L-Asparaginase treatment in adults with acute lymphoblastic leukaemia
- (2012) E Truelove et al. LEUKEMIA
- l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial
- (2011) Carine Domenech et al. BRITISH JOURNAL OF HAEMATOLOGY
- The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols
- (2011) Rachael F. Grace et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel
- (2011) Wendy Stock et al. LEUKEMIA & LYMPHOMA
- Five-year single-center study of asparaginase therapy within the ALL-BFM 2000 trial
- (2011) Dominik Schrey et al. PEDIATRIC BLOOD & CANCER
- Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study
- (2010) L. Mitchell et al. BLOOD
- L-asparaginase treatment in acute lymphoblastic leukemia
- (2010) Rob Pieters et al. CANCER
- Genetic Variations in GRIA1 on Chromosome 5q33 Related to Asparaginase Hypersensitivity
- (2010) S-H Chen et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors
- (2010) B. VAN ZAANE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Conservative treatment of L-asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia
- (2010) Hofit Cohen et al. PEDIATRIC BLOOD & CANCER
- Long-Term Sequelae after Cerebral Venous Thrombosis in Functionally Independent Patients
- (2009) Karen Koopman et al. Journal of Stroke & Cerebrovascular Diseases
- Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis
- (2009) Susan L. Kearney et al. PEDIATRIC BLOOD & CANCER
- Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic
- (2008) Akira Morimoto et al. CANCER
- Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies
- (2008) Gilles Labbe et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study
- (2008) I M Appel et al. LEUKEMIA
- Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia
- (2008) Shu-Fen Wu et al. PEDIATRIC BLOOD & CANCER
- Changes in Background Blood–Brain Barrier Integrity Between Lacunar and Cortical Ischemic Stroke Subtypes
- (2008) Joanna M. Wardlaw et al. STROKE
- L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia
- (2008) Wim C. J. Hop et al. THROMBOSIS AND HAEMOSTASIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search